$2.94 Billion is the total value of HealthCor Management, L.P.'s 46 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 94.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $253,518,000 | +37.8% | 2,325,000 | +52.5% | 8.62% | +44.0% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $215,225,000 | +76.1% | 625,000 | +92.3% | 7.32% | +84.1% |
| MRK | Sell | MERCK & CO INC | $199,241,000 | -9.2% | 3,657,820 | -6.2% | 6.78% | -5.1% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $169,838,000 | -3.2% | 1,050,000 | -4.5% | 5.78% | +1.1% |
| XRAY | New | DENTSPLY SIRONA INC | $144,641,000 | – | 2,875,000 | +100.0% | 4.92% | – |
| BAX | Buy | BAXTER INTL INC | $138,189,000 | +23.9% | 2,124,670 | +23.2% | 4.70% | +29.5% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $132,783,000 | +91.2% | 620,480 | +97.0% | 4.52% | +99.8% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $116,591,000 | +44.3% | 282,420 | +27.5% | 3.96% | +50.7% |
| LIVN | Buy | LIVANOVA PLC | $95,138,000 | +91.1% | 1,075,000 | +72.6% | 3.24% | +99.8% |
| MD | Buy | MEDNAX INC | $76,947,000 | +14.1% | 1,383,200 | +9.6% | 2.62% | +19.3% |
| PCRX | Sell | PACIRA PHARMACEUTICALS INC | $71,645,000 | -43.9% | 2,300,000 | -17.9% | 2.44% | -41.4% |
| A | New | AGILENT TECHNOLOGIES INC | $70,513,000 | – | 1,054,000 | +100.0% | 2.40% | – |
| RDUS | New | RADIUS HEALTH INC | $68,286,000 | – | 1,900,000 | +100.0% | 2.32% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $65,100,000 | – | 1,200,000 | +100.0% | 2.21% | – |
| QGEN | New | QIAGEN NV | $64,841,000 | – | 2,006,840 | +100.0% | 2.20% | – |
| CELG | Sell | CELGENE CORP | $60,755,000 | -66.3% | 681,030 | -60.5% | 2.07% | -64.7% |
| ANTM | Sell | ANTHEM INC | $59,049,000 | -17.0% | 268,770 | -15.0% | 2.01% | -13.3% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $57,354,000 | -51.5% | 691,595 | -54.6% | 1.95% | -49.3% |
| DHR | Buy | DANAHER CORP DEL | $55,609,000 | +380.6% | 567,960 | +355.6% | 1.89% | +401.6% |
| ABBV | Sell | ABBVIE INC | $54,336,000 | -25.0% | 574,070 | -23.4% | 1.85% | -21.7% |
| IQV | Sell | IQVIA HLDGS INC | $54,052,000 | -29.5% | 550,930 | -29.7% | 1.84% | -26.4% |
| MASI | New | MASIMO CORP | $50,571,000 | – | 575,000 | +100.0% | 1.72% | – |
| INCY | New | INCYTE CORPcall | $49,998,000 | – | 600,000 | +100.0% | 1.70% | – |
| GILD | New | GILEAD SCIENCES INC | $49,508,000 | – | 656,690 | +100.0% | 1.68% | – |
| AGN | Sell | ALLERGAN PLC | $49,060,000 | -63.6% | 291,520 | -64.7% | 1.67% | -62.0% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $38,018,000 | +53.3% | 601,080 | +48.5% | 1.29% | +60.2% |
| ABBV | New | ABBVIE INCcall | $37,860,000 | – | 400,000 | +100.0% | 1.29% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $36,573,000 | – | 424,230 | +100.0% | 1.24% | – |
| HAE | Sell | HAEMONETICS CORP | $36,391,000 | -56.8% | 497,410 | -65.7% | 1.24% | -54.8% |
| MDCO | New | MEDICINES CO | $32,453,000 | – | 985,222 | +100.0% | 1.10% | – |
| EVHC | New | ENVISION HEALTHCARE CORP | $31,314,000 | – | 814,840 | +100.0% | 1.06% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $30,964,000 | – | 1,378,000 | +100.0% | 1.05% | – |
| HYH | New | HALYARD HEALTH INC | $28,915,000 | – | 627,500 | +100.0% | 0.98% | – |
| CVRS | CORINDUS VASCULAR ROBOTICS I | $27,375,000 | +35.6% | 19,981,655 | 0.0% | 0.93% | +41.7% | |
| CELG | New | CELGENE CORPcall | $26,763,000 | – | 300,000 | +100.0% | 0.91% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $26,174,000 | – | 1,318,612 | +100.0% | 0.89% | – |
| BIO | New | BIO RAD LABS INCcl a | $25,743,000 | – | 102,940 | +100.0% | 0.88% | – |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $24,413,000 | -77.5% | 149,790 | -79.3% | 0.83% | -76.5% |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $19,947,000 | – | 293,130 | +100.0% | 0.68% | – |
| MTD | New | METTLER TOLEDO INTERNATIONAL | $19,349,000 | – | 33,649 | +100.0% | 0.66% | – |
| XENT | New | INTERSECT ENT INC | $18,269,000 | – | 464,850 | +100.0% | 0.62% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $18,201,000 | – | 769,601 | +100.0% | 0.62% | – |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $15,667,000 | +71.8% | 573,480 | +55.9% | 0.53% | +79.5% |
| INCY | Sell | INCYTE CORP | $10,909,000 | -91.5% | 130,910 | -90.3% | 0.37% | -91.1% |
| MDT | Sell | MEDTRONIC PLC | $9,556,000 | -93.9% | 119,120 | -93.9% | 0.32% | -93.7% |
| ZSAN | New | ZOSANO PHARMA CORP | $2,772,000 | – | 550,000 | +100.0% | 0.09% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -101,000 | -100.0% | -0.07% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -284,400 | -100.0% | -0.21% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INCcall | $0 | – | -100,000 | -100.0% | -0.39% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -244,950 | -100.0% | -0.46% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -166,280 | -100.0% | -0.84% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -194,610 | -100.0% | -0.88% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -2,956,351 | -100.0% | -1.46% | – |
| ZTS | Exit | ZOETIS INCcl a | $0 | – | -645,100 | -100.0% | -1.51% | – |
| HUM | Exit | HUMANA INC | $0 | – | -263,440 | -100.0% | -2.13% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -973,840 | -100.0% | -2.16% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -1,309,960 | -100.0% | -2.37% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -1,125,000 | -100.0% | -2.66% | – |
| BIVV | Exit | BIOVERATIV INC | $0 | – | -3,750,000 | -100.0% | -6.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.